Navicixizumab (Anti-DLL4)
Gecertificeerd

Navicixizumab (Anti-DLL4)

Catalog #: C00314-01
Maat: 1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

CAS Number

1638338-43-8

Synonyms

OMP-305B83; Anti-DLL4 Reference Antibody

SKU

C00314-1mg

Additionnal Information

Navicixizumab (Anti-DLL4) is a bispecific monoclonal antibody targeting DLL4/VEGF. Navicixizumab can combine with Paclitaxel for cancer research. Navicixizumab can be used in the research of ovarian, primary peritoneal, or fallopian tube cancer. MW: 145.5 KD.

Storage Conditions

Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Beschrijving

Navicixizumab (Anti-DLL4) Beschikbaar in 1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamNavicixizumab (Anti-DLL4)
Categorie
Beschikbare grootte1 mg
CatalogusnummerC00314-01